Not only transient effects of short-lived effector CD8 + T cells, but also acquisition of long-term anti-tumor immunity via activation of long-lived memory CD8 + T cells would bring long-term sustained anti-tumor effects in pancreatic cancer. The gene discussed is CD8A; the disease is pancreatic neoplasm.